It is recommended by the American Academy of Pediatrics that babies be breastfed exclusively until about 6 months. At 6 months, a baby’s needs, particularly for certain micronutrients, exceed what can be provided by breast milk alone.
Many parents would like their children to develop taste preferences for a wide variety of foods, particularly healthy foods like vegetables. Food taste and flavor play a large role in food choices and preferences, and both biological and environmental factors influence taste preference in infants.
Many of our staff are now back in the office and receiving calls again, but our chat service is still available. We will operate from 8 AM to 5 PM CST Monday through Friday. If you need to discuss drug use while breastfeeding or during pregnancy please use the button below or call us at 1 (806) 352-2519.
Kratom was on the U.S. Drug Enforcement Agency’s (DEA) list of drugs of concern since 20051 and was almost reclassified as a Schedule I drug in 2016. The reclassification was eventually put on hold due to massive public outcry and Kratom currently remains legal in most states in the U.S.2 However, there is no question that the number of Kratom exposures in the US is on the rise.
The benefits of fish and shellfish, collectively termed “seafood” as part of a balanced, healthy diet have been described. Seafood is low in saturated fat and a good source of high-quality protein and micronutrients including vitamin B12, vitamin D, calcium, iron, and zinc. It is also an important dietary source of polyunsaturated omega-3 fatty acids such as eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) that the human body is unable to make.
Lead is an environmental pollutant that serves no useful purpose in the body and tends to accumulate in the body's bony structures based on their exposure. Some studies show that the half-life of lead in bone is approximately 27 years. Thus you may never get rid of all the lead you have absorbed during your life without chelation therapy. Thus it is best to try and avoid situations with lead exposure.
At present there is enormous concern about the birth defects believed associated with infections for an old virus called Zika during pregnancy. Information concerning the Zika Virus and its implication in microcephaly has been reported in many countries, including the USA.
The amount of a drug that is excreted into breastmilk depends on a number of kinetic factors. Using these kinetic terms, one can frequently estimate the probability that a medications will enter will, but the only true test is the research studies published in the literature. With these in hand we can frequently estimate the absolute dosage an infant will receive from his/her mother's milk.
Depression during pregnancy and postpartum is fairly common, affecting anywhere from 15% to 25% of women. Antidepressants [link antidepressants] are an important part of the treatment arsenal for depression. But clinicians, and women themselves, are increasingly concerned about their use in pregnancy and while breastfeeding. Specifically, do antidepressants taken during pregnancy cause birth defects?
Current studies indicate that approximately 4% of women in the USA use illicit drugs while pregnant. Seventy five percent of these cases report the use of marijuana. Despite the widespread use of this product, the public is not aware of the potential neurobehavioral effects of this drug on the fetus or the newborn infant.
When faced with a health concern, the first place that many people go is the internet. Although having medical advice at your fingertips is convenient, your search bar may not be the best bet for obtaining accurate information. A study done on the validity of information found online regarding Lyme disease showed that many websites, claiming to be leaders in information regarding Lyme disease, were providing inaccurate information, especially about breastfeeding while infected with Lyme disease.
Thomas Hale, Ph.D., R.Ph., is a professor of pediatrics and associate dean of research at Texas Tech University Health Sciences Center and acting executive director of the InfantRisk Center. Hale is considered one of the foremost expert in the field of perinatal pharmacology and the use of medications by pregnant and breastfeeding mothers.
The vision of the InfantRisk Center is to create a new body of drug information concerning the safety of medications and their use during pregnancy and lactation. Additionally, the center will expand, enhance and disseminate knowledge regarding the use of medications and other environmental chemicals by pregnant and breastfeeding women worldwide.
Dr. Teresa Baker
Teresa Baker, MD. graduated from the University of Texas Southwestern and completed her residency training at Parkland Health and Hospital System in Dallas, TX. She is Board Certified by the American Board of Obstetrics and Gynecology and is a Fellow of the American College of Obstetricians and Gynecologists.
Dr. Baker has a combined private and academic OB/GYN practice with the University Physicians at Texas Tech Health Sciences Center in Amarillo. She is interested in teen pregnancy, postpartum depression, and promoting preventive medicine for the women of the Texas Panhandle, as well as Resident and Student education and serves as the Residency Director.
Dr. Christine D. Garner, PhD, RD
Christine D. Garner, PhD, RD, completed her doctorate Nutrition at Cornell University, where she was an NIH Doctoral Trainee in Maternal and Child Nutrition. She was trained as a Registered Dietitian at the University of California San Francisco, where she also worked for several years as a Pediatric Clinical Dietitian.
Garner’s interests involve maternal and child health from a nutritional perspective. The majority of her research has centered on maternal obesity and breastfeeding, and she has used a combination of statistical and qualitative methods to investigate research questions pertaining to these topics.
Dr. Palika Datta, PhD
Palika Datta Ph.D. is a Research Assistant Professor in the Department of Pediatrics at Texas Tech University School of Medicine. She completed her Ph.D. in All India Institute of Medical Sciences. Dr. Datta did postdoctoral work at TTUHSC School of Pharmacy before joining the InfantRisk Center 4 years ago. She has broad experience in conventional biochemistry and molecular biology techniques. Liquid chromatography mass spectrometry, Microarray, Protein expression, purification in mammalian and bacterial cell culture system. Dr. Datta runs and supervises our highly sophisticated clinical pharmacology laboratories.
Kaytlin Krutsch, PharmD, MBA
Kaytlin Krutsch, PharmD, MBA is a board-certified Pharmacotherapy Specialist with a background in nutrition, clinical pharmacy, managed healthcare, and entrepreneurship. She is an assistant professor Assistant Professor of Obstetrics and Gynecology at the Texas Tech University Health Sciences Center School of Medicine.
Dr. Krutsch is pursuing a PhD in translating knowledge to action at The George Washington University. She is passionate about improving the decision-making process when a mom’s need for medication is complicated by breastfeeding and the risks involved with exposing an infant to the drug. This starts with studying which medications transfer into milk and ends with moms making informed decisions.
Kathleen A Rewers-Felkins
Kathleen A Rewers-Felkins is a Research Associate in the Department of Pediatrics at Texas Tech University School of Medicine. She received her Bachelors of Science from Loyola University Chicago and completed her Masters of Science at University of Houston. She has worked for Harrington Cancer Center, including a clinical trial as well as in several TT research labs, involved with cell culture, bacterial culture, PCR assays, animal work and liquid chromatography/mass spectrophotometry.
Dr. Amanda Griffin, MD
Amanda Griffin MD graduated from University of Nebraska Medical Center and completed her residency training in Pediatrics from Texas Tech University School of Medicine. Her practice includes direct patient care as well as supervision and education of residents and students in the outpatient clinic, newborn nursery, and inpatient ward. She also serves the same roles in a clinic for children with special healthcare needs.
Dr. Griffin also helped establish and presently supervised a breastfeeding clinic in the Department of Pediatrics. She supervises a Board Certified Lactation Consultant and helped expand the access of our patients to lactation services in our community. She is a Pediatric hospitalist and admits and cares for inpatients of private pediatricians in Amarillo.
Dr. Mubariiz Naqvi, MD
Dr. Mubariz Naqvi, MD is a long-time member of the Department of Pediatrics. He is Professor of Pediatrics and is a board certified neonatologist. Dr. Naqvi has spent many years supporting the use of human milk in his premature infants. He is a member of the Critical Care Committee, Neonatal Transport Committee, Pediatric Residency Committee, Chair of Education Research Sub-committee, and numerous other hospital and educational committees. Dr. Naqvi is Board Certified by American Academy of Pediatrics with a subspecialty Board of in Subspecialty Board of Neonatal/Perinatal Medicine.
Dr. Rachel Anderson, MD
Rachel Anderson MD is an assistant professor of pediatrics. She graduated from Texas Tech University School of Medicine in 2013 and completed her Pediatric residency at TTUHSC Amarillo in 2016. She has interests in Foster Care, breastfeeding, child abuse and neglect, and other disorders in pediatrics.
Dr. Todd Bell
Todd Bell, MD. is an Associate Professor in the Department of Pediatrics although he is double boarded in Pediatrics and Internal Medicine. He received his MD from the University of Arkansas School of Medicine cum laude in 2001. He completed a combined general internal medicine and general pediatrics residency in Durham, North Carolina at Duke University Medical Center. Dr. Bell has extensive research experience, particularly in influenza, infectious diseases, and dysautonomia.
Sandra Lovato, RN
Sandra Lovato, RN is a Registered Nurse and telephone advisor for the InfantRisk Center. She received her ADN from the Amarillo College of School of Nursing in May of 2008. She began working at the InfantRisk Center in November of 2013 as a Senior Adviser for Dr. Hale. Since she began working under Dr. Hale, she has learned a lot about the effects of medications and their passage into breastmilk. She is glad to be a part of such a valuable and important resource for pregnant and breastfeeding mothers and seeks to help mothers have a long, healthy breastfeeding relationship with their child.
Alicia Gill, RN
Alicia Gill, RN is a Registered Nurse and telephone advisor for the Infant Risk Center. She graduated the Vocational Nursing Program from Clarendon College in 2007. Then she received her ADN from Amarillo College in 2010. She began working at the Infant Risk Center in June of 2019 as a Senior Advisor for Dr. Hale. She has learned a lot about the effects of medications and their passage into breastmilk. She is excited to be a part of an important and valuable research center for pregnant and breast feeding moms.